Teriflunomide for Individual and Family Plans
Cigna coverage policy for teriflunomide (Aubagio and generic teriflunomide tablets) for Individual and Family Plans, defining medical necessity criteria for initiation and continuation in adults with relapsing forms of multiple sclerosis, exclusions, prescribing requirements, and documentation expectations.
Added a definition for documentation.
Added a specialist prescribing requirement.
Added criteria for patient Currently Receiving Teriflunomide for ≥ 1 Year.
Updated the preferred product multi-source brand language to current standards.
Ocrevus Zunovo was added to the Appendix.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.